Price movement over the last 24 hours
Agilent Technologies Inc vs Bank of America Corp — how do they compare? Agilent Technologies Inc trades at $128.23 (market cap $37.04B), while Bank of America Corp trades at $58.62 (market cap $424.80B). The key difference: Bank of America Corp is far larger — about 11.5× Agilent Technologies Inc's market cap, and Bank of America Corp pays the higher dividend (1.87%). Which is the better fit depends on your goals.
| A | BAC | |
|---|---|---|
Market Cap | $37.04B | $424.80B |
Sector | Health | Financials |
52-Week High | $157.20 | $59.90 |
52-Week Low | $110.24 | $44.92 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | 1.87% |
Volume | — | 55,637,172 |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Bank of America (BAC) trades at $59.9, up 1.99% today, near the analyst consensus price target of $63.79. The stock shows strong technical momentum with a bullish moving average signal, though RSI levels indicate potential overbought conditions. Fundamentally, BAC delivered three consecutive quarterly earnings beats, with Q1 2026 EPS of $1.11 exceeding expectations. Revenue grew to $113.1 billion in 2025, and the net income margin improved to 26.97%. Recent news highlights strategic partnerships and a focus on talent acquisition.
BAC presents a favorable outlook with robust earnings growth, a dominant deposit franchise, and positive analyst sentiment (64.8% buy ratings). Key opportunities include potential capital returns post-stress tests and AI-driven efficiency gains. Risks involve interest rate sensitivity, macroeconomic pressures on lending, and regulatory changes. The stock's current valuation (P/E 14.86) appears reasonable relative to historical performance, supporting a constructive view for long-term investors.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →Bank of America Corporation operates as a financial holding company. The Company offers saving accounts, deposits, mortgage and construction loans, cash and wealth management, certificates of deposit, investment funds, credit and debit cards, insurance, mobile, and online banking services. Bank of America serves customers worldwide.
Read more on BAC →